UBS Maintains Neutral Rating on Humana, Raises Price Target to $495
UBS raised its price target on Humana to $495 per share from $405 while maintaining its Neutral rating.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
UBS raised its price target on Humana to $495 per share from $405 while maintaining its Neutral rating.